EyePoint, Inc. (EYPT)
13.50
+0.34
(+2.62%)
USD |
NASDAQ |
May 28, 16:00
13.50
0.00 (0.00%)
After-Hours: 19:11
EyePoint Research and Development Expense (Annual) : 221.04M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Ocular Therapeutix, Inc. | 197.10M |
| Edgewise Therapeutics, Inc. | 149.30M |
| Merck & Co., Inc. | 12.51B |
| Bristol Myers Squibb Co. | 9.492B |
| Arvinas, Inc. | 282.90M |